Merck Foundation, the philanthropic arm of Merck KGaA Germany in partnership with African First Ladies and Ministries of Health, continue their strategy to provide one-year diploma and two-year master degree in both Preventive Cardiovascular Medicine and Diabetes for medical postgraduates from more than 35 African and Asian countries.
Dr. Rasha Kelej, CEO of Merck Foundation and One of 100 Most Influential Africans emphasized, “Amidst the pandemic that has rocked the world, we must not forget people living with other health conditions such as Diabetes and Hypertension because they are the Coronavirus risk groups, therefore, Merck Foundation continues to build Hypertension and Diabetes care training to doctors, in partnership with African First Ladies, Ministries of Health and Academia, Moreover, we also provide training to doctors from Asian countries.”
Merck Foundation has so far enrolled and trained over 183 Medical postgraduates from over 35 countries. As a part of their efforts to build hypertension and diabetes care capacity, Merck Foundation enroll medical postgraduates for One Year Online Diploma and Two Year online master degree in Preventive Cardiovascular Medicine and Diabetes from reputable university in UK. Additionally, they also enroll doctors for a three-month Diabetes Master course from English, French and Portuguese speaking African countries to advance their clinical knowledge in tackling these non-communicable conditions.
“We are committed to enroll more doctors for these courses to be able to build a platform of hypertension and diabetes experts in underserved communities. These online courses is the right strategy to scale up our efforts to improve access to quality healthcare solutions widely and effectively especially during Coronavirus lockdown,” explained Dr. Rasha Kelej.
The program started in 35 countries such as: Bangladesh, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, DR Congo, Ethiopia, Gabon, The Gambia, Ghana, Indonesia, Kenya, Liberia, Malaysia, Mauritius, Mozambique, Myanmar, Namibia, Nepal, Niger, Nigeria, Philippines, Rwanda, Senegal, Sierra Leone, South Africa, Sri Lanka, Tanzania, United Arab Emirates, Uganda, Zambia and Zimbabwe.
About Merck Foundation
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flickr.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.
|Image Caption : Dr. Rasha Kelej, CEO of Merck Foundation acknowledge some of Merck Foundation Alumni, future Diabetes and Hypertension experts in Africa and Asia||click for high-res image|